Takuya Adachi Hiroko Sagara Kenji Hirose Haruo Watanabe
10.3201/eid1101.040145
Emerg Infect Dis
2005 Jan;11(1):172-4.
CC BY
https://pubmed.ncbi.nlm.nih.gov/15714664/
Anti-Infective Agents / pharmacology Ciprofloxacin / pharmacology Drug Resistance, Bacterial / genetics Fluoroquinolones / pharmacology Paratyphoid Fever / drug therapy Salmonella paratyphi A / drug effects
Anti-Infective Agents / pharmacology Ciprofloxacin / pharmacology Drug Resistance, Bacterial / genetics Fluoroquinolones / pharmacology Paratyphoid Fever / drug therapy Salmonella paratyphi A / drug effects Case Reports Letter Aged Aged, 80 and over Anti-Infective Agents / therapeutic use Bacterial Proteins / genetics Carrier State / drug therapy Carrier State / microbiology Ciprofloxacin / therapeutic use Female Fluoroquinolones / therapeutic use Humans Microbial Sensitivity Tests Paratyphoid Fever / microbiology Salmonella paratyphi A / genetics Anti-Infective Agents Bacterial Proteins Fluoroquinolones Ciprofloxacin
PMC3294367
15714664
Fluoroquinolone-resistant Salmonella Paratyphi A
2005